These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

905 related articles for article (PubMed ID: 29049853)

  • 21. Insights into O-linked N-acetylglucosamine ([0-9]O-GlcNAc) processing and dynamics through kinetic analysis of O-GlcNAc transferase and O-GlcNAcase activity on protein substrates.
    Shen DL; Gloster TM; Yuzwa SA; Vocadlo DJ
    J Biol Chem; 2012 May; 287(19):15395-408. PubMed ID: 22311971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. O-GlcNAc cycling: a link between metabolism and chronic disease.
    Bond MR; Hanover JA
    Annu Rev Nutr; 2013; 33():205-29. PubMed ID: 23642195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulating the Regulators: Mechanisms of Substrate Selection of the O-GlcNAc Cycling Enzymes OGT and OGA.
    Stephen HM; Adams TM; Wells L
    Glycobiology; 2021 Aug; 31(7):724-733. PubMed ID: 33498085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nutrient-driven O-GlcNAc cycling - think globally but act locally.
    Harwood KR; Hanover JA
    J Cell Sci; 2014 May; 127(Pt 9):1857-67. PubMed ID: 24762810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. O-GlcNAc modifications regulate cell survival and epiboly during zebrafish development.
    Webster DM; Teo CF; Sun Y; Wloga D; Gay S; Klonowski KD; Wells L; Dougan ST
    BMC Dev Biol; 2009 Apr; 9():28. PubMed ID: 19383152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracellular and extracellular O-linked N-acetylglucosamine in the nervous system.
    Ogawa M; Sawaguchi S; Kamemura K; Okajima T
    Exp Neurol; 2015 Dec; 274(Pt B):166-74. PubMed ID: 26278182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of transcription factor function by O-GlcNAc modification.
    Ozcan S; Andrali SS; Cantrell JE
    Biochim Biophys Acta; 2010; 1799(5-6):353-64. PubMed ID: 20202486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hexosamine biosynthetic pathway and
    Kim DY; Park J; Han IO
    Am J Physiol Cell Physiol; 2023 Oct; 325(4):C981-C998. PubMed ID: 37602414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of
    Chatham JC; Zhang J; Wende AR
    Physiol Rev; 2021 Apr; 101(2):427-493. PubMed ID: 32730113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic O-GlcNAcylation and its roles in the cellular stress response and homeostasis.
    Groves JA; Lee A; Yildirir G; Zachara NE
    Cell Stress Chaperones; 2013 Sep; 18(5):535-58. PubMed ID: 23620203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. You are what you eat: O-linked N-acetylglucosamine in disease, development and epigenetics.
    Olivier-Van Stichelen S; Hanover JA
    Curr Opin Clin Nutr Metab Care; 2015 Jul; 18(4):339-45. PubMed ID: 26049631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding and exploiting the roles of O-GlcNAc in neurodegenerative diseases.
    Pratt MR; Vocadlo DJ
    J Biol Chem; 2023 Dec; 299(12):105411. PubMed ID: 37918804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. O-GlcNAc-modification of SNAP-29 regulates autophagosome maturation.
    Guo B; Liang Q; Li L; Hu Z; Wu F; Zhang P; Ma Y; Zhao B; Kovács AL; Zhang Z; Feng D; Chen S; Zhang H
    Nat Cell Biol; 2014 Dec; 16(12):1215-26. PubMed ID: 25419848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. O-GlcNAc cycling: implications for neurodegenerative disorders.
    Lazarus BD; Love DC; Hanover JA
    Int J Biochem Cell Biol; 2009 Nov; 41(11):2134-46. PubMed ID: 19782947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemical tools to explore nutrient-driven O-GlcNAc cycling.
    Kim EJ; Bond MR; Love DC; Hanover JA
    Crit Rev Biochem Mol Biol; 2014; 49(4):327-42. PubMed ID: 25039763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential role of O-GlcNAc modification in cancer epigenetics.
    Forma E; Jóźwiak P; Bryś M; Krześlak A
    Cell Mol Biol Lett; 2014 Sep; 19(3):438-60. PubMed ID: 25141978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant O-GlcNAc-modified proteins expressed in primary colorectal cancer.
    Phueaouan T; Chaiyawat P; Netsirisawan P; Chokchaichamnankit D; Punyarit P; Srisomsap C; Svasti J; Champattanachai V
    Oncol Rep; 2013 Dec; 30(6):2929-36. PubMed ID: 24126823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A little sugar goes a long way: the cell biology of O-GlcNAc.
    Bond MR; Hanover JA
    J Cell Biol; 2015 Mar; 208(7):869-80. PubMed ID: 25825515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional O-GlcNAc modifications: implications in molecular regulation and pathophysiology.
    Vaidyanathan K; Durning S; Wells L
    Crit Rev Biochem Mol Biol; 2014; 49(2):140-163. PubMed ID: 24524620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. O-GlcNAc transferase and O-GlcNAcase: achieving target substrate specificity.
    Nagel AK; Ball LE
    Amino Acids; 2014 Oct; 46(10):2305-16. PubMed ID: 25173736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.